Would an endotoxin test distinguish racemisation from a synthesis impurity in survodutide?

What I am working with: an endotoxin test · racemisation · survodutide.

I suspect the honest answer is that it depends, in which case I would like to know on what.

Assume I can obtain either option without difficulty, so availability is not the deciding factor.

Is there a defensible reason to prefer one, or is this a coin flip?

Put another way, the most common trap is reading a certificate as if it were a guarantee when it is actually a single point estimate from a single test.

Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.

The relevant detail is that a purity figure to two decimal places with no supporting chromatogram is giving false precision and is a red flag on the same level as spelling errors.

The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

The certificate is only as useful as the lot number, because without traceability it is gossip about someone else's material.

A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.

The field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.

Industry guidance on this topic is consistent because it comes from first principles rather than convention.

One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.

If the certificate does not trace to your vial, it is not evidence about your vial.

Put another way, a useful certificate has five elements: the lot number, the analytical method, the reported result with units, the date of analysis, and the primary data or a reference to it.

Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.

Be careful not to over-read this — a certificate that is imperfect is not worthless, it is just a starting point for thought rather than an endpoint.

My working rule is that a document without a lot number, a method section and a test date is marketing.

On the detail: ask whether the certificate answers the question you are actually asking, because the answer is often no.

The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.

Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.

Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.